Levin Capital Strategies, L.P. Prime Medicine, Inc. Transaction History

Levin Capital Strategies, L.P.

  • $1.03 Billion
  • Q3 2024

A detailed history of Levin Capital Strategies, L.P. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 30,000 shares of PRME stock, worth $86,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,000
Holding current value
$86,400
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.41 - $6.7 $102,300 - $201,000
30,000 New
30,000 $116,000
Q1 2024

May 16, 2024
BUY
$6.35 - $9.39 $41,275 - $61,035
6,500 Added 32.5%
26,500 $185,000
Q4 2023

Feb 06, 2024
BUY
$5.59 - $9.55 $111,800 - $191,000
20,000 New
20,000 $177,000
Q2 2023

Jul 31, 2023
BUY
$11.41 - $17.05 $228,200 - $341,000
20,000 New
20,000 $293,000
Q4 2022

Feb 13, 2023
BUY
$15.2 - $21.12 $160,892 - $223,555
10,585 New
10,585 $196,000

Others Institutions Holding PRME

# of Institutions
123
Shares Held
64.7M
Call Options Held
324K
Put Options Held
64.4K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $276M
More about PRME
Track This Portfolio

Track Levin Capital Strategies, L.P. Portfolio

Follow Levin Capital Strategies, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email